Murottal as Adjunctive Intervention in Pediatric

StatusCompleted
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Eligibility criteria shortened, about 7 words
    • Secondary endpoints: details revised at 2 of 2 entries
    • Study description expanded, about 135 words
  2. Study First Submitted
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Universitas Airlangga
6 trials monitored
See all monitored trials
Anxiety
3,284 trials monitored
See 154 trials at risk
Leukemia
2,957 trials monitored
See 176 trials at risk
Acute Myeloid Leukemia (AML)
1,275 trials monitored
See 74 trials at risk
and 1 more disease
This study aims to evaluate whether listening to the recitation of Surah Ar-Rahman (Murottal) before bedtime can help improve anxiety and sleep quality in hospitalized children with blood cancer. Twenty children aged 8-12 years will be divided into two groups: one group will receive standard care plus the Murottal intervention for 7 days, while the other group will receive standard care only. Anxiety and sleep quality will be measured using validated questionnaires (SCARED and SDSC) before and after the intervention. We hope this study will provide evidence that Murottal can be a safe, non-invasive, and culturally appropriate supportive therapy for pediatric cancer patients.
Trial Details
NCT Number NCT07861477
Lead Sponsor Universitas Airlangga
Collaborators: Universitas Airlangga Hospital, Surabaya
Conditions
(from sponsor)		 Pediatric Cancer, Hematologic Malignancies, Anxiety, Sleep Disturbances in Children, Leukemia (Both ALL and AML)
Related terms Anxiety Disorders, Hematologic Neoplasms, Leukemia, Leukemia, Myeloid, Acute, Neoplasms, Parasomnias
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov